PD Dr. Adelheid Cerwenka
© dkfz.de
Group Leader, Boveri Junior Research Group Innate Immunity
DKFZ - German Cancer Research Center, Heidelberg
Adelheid (Heidi) Cerwenka is Head of the Boveri Junior Research Group “Innate Immunity” in the German Cancer Research Center in Heidelberg. She received a doctorate from the University of Vienna, Austria, and the Venia Legendi from the Faculty of Medicine, University of Heidelberg. After her postdoctoral research at the Trudeau Institute New York, USA and UCSF, San Francisco, USA, she became group-leader at the Novartis Research Institute, Vienna before being appointed as group-leader at the DKFZ. Adelheid Cerwenka is author of more than 50 publications and member of the German Society for Immunology and the Society for Natural Immunity. She serves as reviewer for several journals (e.g. Nature Immunology, JEM, Cancer Research) and national and international grant agencies. In 2008 she was awarded with the Georges Koehler Award of the DGfI. Her research was funded by a Marie Curie Excellence Grant and by several grant agencies (e.g. Dt. Krebshilfe and Carreras foundation).
Her research topics are
- innate immune responses against tumors
- natural killer cells and cancer
- myeloid cell subsets in cancer